Prognostic impact of EGFR and cytokeratin 5/6 immunohistochemical expression in triple-negative breast cancer.

Abdelrahman, Aziza E; Rashed, Hayam E; Abdelgawad, Mohamed; Abdelhamid, Mohamed I

Abdelrahman, Aziza E; Rashed, Hayam E; Abdelgawad, Mohamed; Abdelhamid, Mohamed I.

Afiliação

Abdelrahman AE; Pathology Department, Faculty of Medicine, Zagazig University, Egypt. Electronic address: azaelsayed@gmail.com.
Rashed HE; Pathology Department, Faculty of Medicine, Zagazig University, Egypt.
Abdelgawad M; Clinical oncology Department, Faculty of Medicine, Zagazig University, Egypt.
Abdelhamid MI; General Surgery Department, Faculty of Medicine, Zagazig University, Egypt.

Ann Diagn Pathol ; 28: 43-53, 2017 Jun.

Article em En | MEDLINE | ID: mdl-28648939

Assuntos

Receptores ErbB/metabolismo; Queratina-5/metabolismo; Queratina-6/metabolismo; Linfonodos/patologia; Neoplasias de Mama Triplo Negativas/patologia; Biomarcadores Tumorais/análise; Quimioterapia Adjuvante/métodos; Intervalo Livre de Doença; Feminino; Humanos; Imuno-Histoquímica/métodos; Metástase Linfática; Masculino; Prognóstico; Receptores de Progesterona/metabolismo; Neoplasias de Mama Triplo Negativas/diagnóstico; Neoplasias de Mama Triplo Negativas/metabolismo

Palavras-chave

Cytokeratin 5/6; EGFR; Neoadjuvant chemotherapy; Triple negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Queratina-5 / Queratina-6 / Neoplasias de Mama Triplo Negativas / Receptores ErbB / Linfonodos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google